Error or Terror: Controlling Emerging Technology
By John Drzik,
CNBC
| 01. 15. 2015
Innovation is vital to progress. Advances in science, have propelled economic and societal development throughout history. Today's emerging technologies have the potential to increase global prosperity and tackle major global challenges.
However, innovation also creates risks. Understanding the hazards that can stem from new technologies is critical to avoiding potentially catastrophic consequences.
The recent wave of cyber-attacks exemplify how new technologies can be exploited for malicious ends and create new threats to global safety. Risk governance needs to keep pace with advances in scientific innovation.
Synthetic biology and artificial intelligence are two examples of the "next cyber"; emerging technologies with the capacity to deliver enormous benefits but which also present significant challenges to government, industry and society.
Take synthetic biology: creating new organisms from the building blocks of DNA offers the potential to fight infectious disease, treat neurological disorders, alleviate worries about food security and create biofuels.
The flipside is that the genetic manipulation of organisms could also create significant harm, through error or terror. The accidental leakof dangerous synthetized organisms, perhaps in the form of deadly viruses or plant...
Related Articles
By Nicholas Wade, The New York Times | 04.30.2026
“J. Craig Venter” via Wikimedia Commons licensed under CC by 2.5
J. Craig Venter, a scientist and entrepreneur who raced to decode the human genome, died on Wednesday in San Diego. He was 79.
His death was announced by...
By Susan Dominus, The New York Times Magazine | 04.27.2026
Why are babies born young? The most natural phenomenon on earth is actually hard to explain — at least on a cellular level. Consider this problem: The components of conception are old. When a woman gets pregnant, she has...
By Alfonso Martinez Arias, Nicolas Rivron, and Naomi Moris, BioNews | 04.20.2026
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...